title: Anturan for secondary prophylaxis of myocardial infarction.
abstract: 273 patients suffering from ischemic heart disease were treated with Anturan for one year at a daily dosage of 800 mg. The number of cardiovascular complications was significantly reduced, compared to the control group.
authors: Department of Internal Medicine, Lumumba University, USSR.
authors: I N
authors: IN
authors: Bokarev
authors: V A
authors: VA
authors: Lusov
authors: A P
authors: AP
authors: Golikov
authors: V V
authors: VV
authors: Ptushkin
authors: T V
authors: TV
authors: Zvereva
authors: M P
authors: MP
authors: Savenkov
authors: M V
authors: MV
authors: Seregina
mesh_terms: D000319:Adrenergic beta-Antagonists / Q000008:administration & dosage / Q000627:therapeutic use; D004232:Diuretics / Q000008:administration & dosage / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005260:Female; D005960:Glucosides / Q000008:administration & dosage / Q000627:therapeutic use; D006801:Humans; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000401:mortality / Q000517:prevention & control*; D013442:Sulfinpyrazone / Q000008:administration & dosage / Q000627:therapeutic use*
chemical_list: D000319:Adrenergic beta-Antagonists; D004232:Diuretics; D005960:Glucosides; D013442:Sulfinpyrazone